Search

Titilayo Moloye

Examiner (ID: 2273, Phone: (571)270-1094 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
610
Issued Applications
327
Pending Applications
113
Abandoned Applications
206

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19826453 [patent_doc_number] => 12247219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells [patent_app_type] => utility [patent_app_number] => 17/348174 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 9247 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348174 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/348174
Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells Jun 14, 2021 Issued
Array ( [id] => 17126483 [patent_doc_number] => 20210301251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN [patent_app_type] => utility [patent_app_number] => 17/344064 [patent_app_country] => US [patent_app_date] => 2021-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344064 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/344064
Methods for generating and using organoids and tissue therein Jun 9, 2021 Issued
Array ( [id] => 18510060 [patent_doc_number] => 20230226158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/000957 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000957 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000957
COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS Jun 7, 2021 Pending
Array ( [id] => 17113704 [patent_doc_number] => 20210294301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD AND APPARATUS FOR A TISSUE ENGINEERING SYSTEM UTILIZING STACKED LAYERS [patent_app_type] => utility [patent_app_number] => 17/340434 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13249 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/340434
METHOD AND APPARATUS FOR A TISSUE ENGINEERING SYSTEM UTILIZING STACKED LAYERS Jun 6, 2021 Pending
Array ( [id] => 19449215 [patent_doc_number] => 20240309345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => COMPOSITIONS AND METHODS FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 17/999756 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999756
COMPOSITIONS AND METHODS FOR GENE EDITING May 31, 2021 Pending
Array ( [id] => 19449215 [patent_doc_number] => 20240309345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => COMPOSITIONS AND METHODS FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 17/999756 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999756
COMPOSITIONS AND METHODS FOR GENE EDITING May 31, 2021 Pending
Array ( [id] => 17604268 [patent_doc_number] => 11332741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-05-17 [patent_title] => Compositions and methods for treating leber's hereditary optic neuropathy [patent_app_type] => utility [patent_app_number] => 17/320388 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320388 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320388
Compositions and methods for treating leber's hereditary optic neuropathy May 13, 2021 Issued
Array ( [id] => 18995995 [patent_doc_number] => 11912823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Methods of preparing a poloxamer for use in cell culture medium [patent_app_type] => utility [patent_app_number] => 17/319886 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22570 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319886
Methods of preparing a poloxamer for use in cell culture medium May 12, 2021 Issued
Array ( [id] => 20316135 [patent_doc_number] => 12454679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-28 [patent_title] => Non-decellularized plant leaf cultures for meat [patent_app_type] => utility [patent_app_number] => 17/317037 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 42 [patent_no_of_words] => 3478 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 347 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317037
Non-decellularized plant leaf cultures for meat May 10, 2021 Issued
Array ( [id] => 20316135 [patent_doc_number] => 12454679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-28 [patent_title] => Non-decellularized plant leaf cultures for meat [patent_app_type] => utility [patent_app_number] => 17/317037 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 42 [patent_no_of_words] => 3478 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 347 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317037
Non-decellularized plant leaf cultures for meat May 10, 2021 Issued
Array ( [id] => 17960315 [patent_doc_number] => 20220340895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY [patent_app_type] => utility [patent_app_number] => 17/317295 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317295
COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY May 10, 2021 Abandoned
Array ( [id] => 17355410 [patent_doc_number] => 20220016206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => ISOFORM NELL-1 PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/315593 [patent_app_country] => US [patent_app_date] => 2021-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315593 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315593
Isoform Nell-1 peptide May 9, 2021 Issued
Array ( [id] => 18964417 [patent_doc_number] => 11898169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors [patent_app_type] => utility [patent_app_number] => 17/239059 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 11515 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/239059
Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors Apr 22, 2021 Issued
Array ( [id] => 16990225 [patent_doc_number] => 20210228645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL [patent_app_type] => utility [patent_app_number] => 17/227497 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227497
METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL Apr 11, 2021 Pending
Array ( [id] => 16990225 [patent_doc_number] => 20210228645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL [patent_app_type] => utility [patent_app_number] => 17/227497 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227497
METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL Apr 11, 2021 Pending
Array ( [id] => 16961569 [patent_doc_number] => 20210213068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION [patent_app_type] => utility [patent_app_number] => 17/219430 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219430
PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION Mar 30, 2021 Pending
Array ( [id] => 17814310 [patent_doc_number] => 11419898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Combinatorial cancer immunotherapy [patent_app_type] => utility [patent_app_number] => 17/219569 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 122 [patent_no_of_words] => 62423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219569 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219569
Combinatorial cancer immunotherapy Mar 30, 2021 Issued
Array ( [id] => 16913995 [patent_doc_number] => 20210187087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS [patent_app_type] => utility [patent_app_number] => 17/191378 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191378
TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS Mar 2, 2021 Abandoned
Array ( [id] => 16913975 [patent_doc_number] => 20210187067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 [patent_app_type] => utility [patent_app_number] => 17/178127 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178127 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178127
TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 Feb 16, 2021 Abandoned
Array ( [id] => 16822763 [patent_doc_number] => 20210138056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/148324 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148324 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148324
NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF Jan 12, 2021 Abandoned
Menu